Activist 13D/13G Filings - Invenomic Capital Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-14
12:00 pm
Purchase		13GLEXARIA BIOSCIENCE CORP
LEXXW		Invenomic Capital Management LP731,981
7.120%		258,878increase
(+54.72%)		View
2024-02-14
12:00 pm
Sale		13GUNIFI INC
UFI		Invenomic Capital Management LP813,753
4.490%		-130,537decrease
(-13.82%)		View
2024-02-14
12:00 pm
Sale		13GViant Technology Inc.
DSP		Invenomic Capital Management LP439,371
2.830%		-364,019decrease
(-45.31%)		View
2023-02-10
4:26 pm
Purchase		13GUNIFI INC
UFI		Invenomic Capital Management LP944,290
5.240%		944,290increase
(New Position)		View
2023-02-10
4:17 pm
Purchase		13GViant Technology Inc.
DSP		Invenomic Capital Management LP803,390
5.640%		803,390increase
(New Position)		View
2023-02-10
4:06 pm
Purchase		13GLEXARIA BIOSCIENCE CORP
LEXXW		Invenomic Capital Management LP473,103
7.950%		113,990increase
(+31.74%)		View
2022-03-10
4:00 pm
Sale		13GIMMERSION CORP
IMMR		Invenomic Capital Management LP1,669,161
4.980%		-29,394decrease
(-1.73%)		View
2022-02-11
5:46 pm
Purchase		13GIMMERSION CORP
IMMR		Invenomic Capital Management LP1,698,555
5.140%		1,698,555increase
(New Position)		View
2022-02-11
5:33 pm
Purchase		13GLEXARIA BIOSCIENCE CORP
LEXXW		Invenomic Capital Management LP359,113
6.030%		359,113increase
(New Position)		View